Cardiology Headline News

Aortic stiffness, a known risk factor for cardiovascular disease, was raised among patients with alpha-1 antitrypsin deficiency vs. patients with COPD or healthy individuals, according to study results.

DENVER — Incorporating artificial intelligence into daily practice can benefit both providers and patients, according to experts here at the American Academy of Neurology annual meeting.

Abbott/Thoratec Corp. issued a recall of two of its left ventricular assist devices due to risk for obstruction from the long-term buildup of biological material during use.

ATLANTA — Preventive PCI plus optimal medical therapy was superior to optimal medical therapy alone for patients with nonflow-limiting vulnerable coronary plaques, according to the results of the PREVENT trial.

ATLANTA — A phone-based telehealth model improved rates of guideline-directed classes of HF drugs filled at the pharmacy at 30 days among adults with HF with reduced ejection fraction in Navajo Nation, where access to care is limited.

Among habitual waterpipe smokers, brachial and aortic blood pressure, as well as heart rate, rose after 30-minute outdoor use of the pipe, according to results published in CHEST.

Patients receiving daily tofacitinib doses of 10 mg for rheumatoid arthritis demonstrate an increased risk for venous thromboembolism and pulmonary embolism, compared with those taking TNF inhibitors, according to data.

Physical activity patterns dominated by vigorous exercise, housework or walking lowered stroke risk, whereas patterns with greater commuting or TV watching increased that risk, according to a prospective cohort study published in Stroke.

Building community partnerships, having community specialists within a care team and using screening tools are all necessary steps to identifying and addressing social needs, according to experts.

ATLANTA — In this Healio video exclusive, Pamela S. Douglas, MD, MACC, FASE, FAHA, discusses an American College of Cardiology initiative created to increase diversity and equity in clinical trials research leadership.